Smith RM,Wu GY .1999 .M mbaemdyialatseedidnevfiicvoiegnecnye.JtInhheerritaMpetyfaobrDoisr1n9i9t8h;in21et(sruapnpsc1)a. r, 37 : 83-92.
.1998 .Hepatocytegrowth correctioonf hemophilia A afterin vivoretrovirgaelne factorinduceshepatocyteproliferatio nin vivo and^ ■ transfeirn factor-VIIdIeficientmice. ProdNatlAcadSciUSA allows forefficientretroviral-mediatgeednetransfeirn ■. Hepatology, 28 : 707-16.
Huber BE .1994 .Genetherapy-promisepsr,oblems| enzyme/prodrugtherapy(VDEPT): selectivelyengineeringdrug sensitivityinto tumors. Ann NY Acad Sc/ and prospectsN.ature, 716 : 104-14.
.1993 .Adenovirus-mediatetdransfeorf low-densitylipoproteinreceptogreneacutelyacceler atescholesterocllearancein normalmice. ProcNatlAcad SciUSA, 90 : 2812-6.
Kaneko S,Jaffe HA,HurfordRK JR,Yang Y,Li Q .1992 .Genetherapyof mediatedin vivo genetransfearnd expressio nin normetastaticancerby in vivo retrovirgael netargeting. mal ratliver. Cellularand humoral immune I NatGenets, 995 : 430-5.
Joyce GF .1995 .A generalpurposeRNA-cleav- directegdene therapywith recombinantAdenovirus. I ing DNA enzyme. JViroi, 67 : 2004-15.
Wu CH,Seek J,lian Y,Jona VK,Sengupta K .1998 .. areactiveagainstIntracellulahrepatitisB viralRNA targetsH.epatology, 28 : 547-54.
Wu GY,Wu CH .1992 .Specificinhibitionof hepatitisB viral gene expressionin vitroby targetedantisense oligonucleotidesJ. BiolChem, 267 : 12496-9.
.1993 .In vivo inhibitionof duckhepatitisB virusreplicationand gene expressionby phosphorothioatmeodified antisense oligodeoxynucleotidesE. MBOJ, 12 : 1257-62.
Zhang H,Hanecak R .1999 .Antisense oligonucleotideinhibition of hepatitisC virusgene expressionin liversof mice infectedwithan HCV-vaccinia virusrecombinantA. ntimicrob Agents Chemother, 43 : 347-53.
Wu CH,Wu GY .1998 .Targete dinhibitionof hepatitisC virusdirectedgene expressionin human hepatoma cell lines. Gastroenterology, 114 : 1304-12.
Yoon K,Cole-StrausAs K .1996 .Targetedgene correctioonf episomal DNA in mammalian cellsmediatedby a chimericRNA/DNA oligonucletide. Proc Natl AcadSc/USA, 93 : 2071-6.
Kren BT,Cole-StraussA BT .1997 .Targeted nucleotideexchangein thealkalinephosphatasegene of HuH-7 cells mediatedby a chimericRNA/DNA oligonucleotideH. epatology, 25 : 1462-8.
.1997 .pressionwith FK506 permitslong-termexpressionof therapeuticgenes introducedinto the liver using recombinanatdenovirusesH. epatology, 26 : 949-56.
Yang Y,Nunes FA .1994 .recombinantadenoviruseslimits cellularimmun! and improvestheprospecotf gene therapyof cystic fibrosisN. atGenet, 7 : 1i5-9.
Lee MG .1995 .Theconstitutiveexpres sion of the immunomodulatorygp 19K proteinin E1-, E3-adenoviralvectorstronglyreducethe host cytotoxicT cell responseagainstthevectorG. ene Ther, 2 : 256-62.
Amalfitanao ,McVie-WylieAJ .1999 .Systemiccorrection of themuscledisordegrlycogenstoragediseasetype II afterhepatictargetinogf a modifiedAdenovirusvectorencoding human acid-alpha-glucosidaseP. roc Natl AcadSciUSA, 96 : 8861-6.
Wang L .1999 .Sustained correctioonf bleedingdisordeirn hemophilia B mice by genetherapyP. rocNatlAcadSciUSA, 96 : 3906-10.
.1999 .Gene therapyTo the liverusier. simian-virus40-derivedvectorsS.emin LiverDis, 1 : 71-81.
Feng M .1997 .a novel strategtyoachievehigh-efficit cystabletransductioinn vivo. FASEBJ, 11 : 624.
Gao X .1997 .Biochem tocytesmediatedby helpervirus-freHeSV/AAV hybrid. MoiMed, 3 : 813-25.